Johnson & Johnson NYSE JNJ
$145.74 0.97 0.67%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 46 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

354.25B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

361.72B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

0.72
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

2.43B
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-7.02 %
Upcoming events Johnson & Johnson All events
No upcoming events scheduled

Stock chart Johnson & Johnson

Stock analysis Johnson & Johnson

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
10.08 12.12
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
5.15 5.12
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
11.68 17.36
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.24 1.38
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
51.11 27.27

Price change Johnson & Johnson per year

130.31$ 178.93$
Min Max

Summary analysis Johnson & Johnson

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Johnson & Johnson

Revenue and net income Johnson & Johnson

All parameters
Stock news Johnson & Johnson All news

Johnson & Johnson купит Shockwave Medical за $12,5 млрд

Johnson & Johnson's Application for Tecvayli Gets FDA Approval

Johnson & Johnson's Application for Tecvayli Gets FDA Approval

Washington state reaches nearly $150 million settlement with Johnson & Johnson over opioid crisis

Dow's nearly 150-point drop led by losses in 3M, Johnson & Johnson shares

Dow's nearly 150-point drop led by losses in 3M, Johnson & Johnson shares

Johnson & Johnson to Pay $700 Million to Settle Baby Powder Probe

Johnson & Johnson 4Q Sales Beat Expectations Led by U.S. Growth

Johnson & Johnson 4Q Sales Beat Expectations Led by U.S. Growth

Johnson & Johnson Q4 earnings beat estimates amid strength in medtech

Johnson & Johnson Expected to Post 4Q Net Income Growth, Lower Revenue -- Earnings Preview

Johnson & Johnson Expected to Post 4Q Net Income Growth, Lower Revenue -- Earnings Preview

Ambrx Biopharma Shares Double on $2B Acquisition by Johnson & Johnson

Ambrx Biopharma Shares Double on $2B Acquisition by Johnson & Johnson

Johnson & Johnson to Acquire Amrbx for $2B

Johnson & Johnson to acquire Ambrx in $2 billion deal

Johnson & Johnson Earnings to Be Hit by Loss of Stelara Exclusivity, Wells Fargo Says

Integra LifeSciences to Buy Acclarent From Johnson & Johnson

Integra LifeSciences to Buy Acclarent From Johnson & Johnson

Johnson & Johnson Ticks Higher Following Guidance Release

About company Johnson & Johnson

Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Address:
One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933
Company name: Johnson & Johnson
Issuer ticker: JNJ
ISIN: US4781601046
Country: USA
Exchange: NYSE
Currency: $
IPO date: 1944-09-24
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.jnj.com

On which stock exchange are Johnson & Johnson (JNJ) stocks traded?

Johnson & Johnson (JNJ) stocks are traded on NYSE.

What is the ticker of Johnson & Johnson stocks (JNJ)?

The stock ticker of Johnson & Johnson’s stocks or in other words, the code is JNJ. The stocks are currently listed on the NYSE exchange.

In which sector and industry does Johnson & Johnson (JNJ) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Johnson & Johnson (JNJ) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Johnson & Johnson (JNJ) stocks traded?

Johnson & Johnson (JNJ) stocks are traded on the NYSE exchange in dollars.

What is the price of Johnson & Johnson (JNJ) stocks today?

The current price of Johnson & Johnson stocks on 19.04.2024 is 145.74 dollars. per share.

What is the dynamics of Johnson & Johnson (JNJ) stocks from the beginning of the year?

Johnson & Johnson (JNJ) quotes have increased by -8.9% from the beginning of the year up to 145.74 dollars. per 1 stocks.

How much did Johnson & Johnson (JNJ) stocks increase in апреле 2024?

This month Johnson & Johnson (JNJ) quotes have increased by -7.63% to 145.74 dollars. per share.

How much are Johnson & Johnson (JNJ) stocks worth?

Today, on October, 19.04.2024 Johnson & Johnson’s (JNJ) stocks cost 145.74 dollars..

What is the market capitalization of Johnson & Johnson (JNJ)?

Capitalization is the market value of Johnson & Johnson (JNJ) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 19.04.2024, the market capitalization of Johnson & Johnson (JNJ) is estimated at about 354250218000 dollars.